Biosimilars are defined as the follow-on versions of original biological medicines. These are separately developed after the patent protecting the original product has expired. Biosimilars are intended to have the same MOA as original biological drugs and are designed to treat the same diseases as the innovator’s product. They have many similarities, but are not identical to, the reference biopharmaceutical product.
Publisher’s analysts forecast the global biosimilars market to grow at a CAGR of 55.52% during the period 2016-2020.
Complete Report Available at: http://www.reportsweb.com/global-biosimilars-market-2016-2020 .
Covered in this report
The report covers the present scenario and the growth prospects of the global biosimilars market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sale of products such as somatropin, erythropoietin, colony-stimulating factors (CSF), interferons, interleukins, insulin and insulin analogs, follicle stimulating hormones (FSH), monoclonal antibodies (mAbs), and low molecular weight heparins (LMWH).
The market is divided into the following segments based on geography:
– Americas
– APAC
– EMEA
Publisher’s report, Global Biosimilars Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
– Biocon
– Celltrion
– Dr. Reddy’s Laboratories
– Hospira
– Sandoz
– STADA
– Teva Pharmaceuticals
Purchase this Premium Research Report at: http://www.reportsweb.com/buy&RW0001345914/buy/2500 . (Priced at US$ 2500)
Other prominent vendors
– 3SBio
– Accord Healthcare
– AET Biotech
– Allergan
– Alvartis Pharma
– Amega Biotech
– Amgen
– Apotex
– Aspen
– AstraZeneca
– Aurobindo Pharma
– Baxter
– Bharat Serums
– Bio Sidus
– Biogen
– Bionovis
– Bioton
– BioXpress Therapeutics
– Boehringer Ingelheim
– Boston Oncology
– Cipla
– Coherus Biosciences
– Daiichi Sankyo
– Emcure Pharmaceuticals
– Gedeon Richter
– GeneScience Pharmaceuticals
– GSK
– Hetero Drugs
– iBio
– Intas Pharmaceuticals
– JCR Pharmaceuticals
– LG Lifesciences
– Lonza
– Merck
– Mitsubishi Tanabe Pharma
– Momenta Pharmaceuticals
– Mylan
– Natco Pharma
– Novartis
– Pfenex
– Pfizer
– Ranbaxy Laboratories
– Roche Holding
– Samsung Biologics
– Sanofi
– Synthon
– Wockhardt
– Zydus Cadila Healthcare
Get Sample Report at: http://www.reportsweb.com/inquiry&RW0001345914/sample
Table of Contents:
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Market research methodology
PART 04: Introduction
PART 05: Pipeline portfolio
PART 06: Market landscape
PART 07: Market segmentation by application
PART 08: Market segmentation by end-user
PART 09: Geographical segmentation
PART 10: Market drivers
PART 11: Impact of drivers
PART 12: Market challenges
PART 13: Impact of drivers and challenges
PART 14: Market trends
PART 15: Vendor landscape
PART 16: Appendix
PART 17: Explore Publisher
Inquire about Report at: http://www.reportsweb.com/inquiry&RW0001345914/buying
Media Contact
Company Name: ReportsWeb
Contact Person: Rajat Sahni
Email: sam@reportsweb.com
Phone: +1-646-491-9876
Country: United States
Website: http://www.reportsweb.com/global-biosimilars-market-2016-2020